NEU 3.50% $14.05 neuren pharmaceuticals limited

Acadia, page-82

  1. 3,450 Posts.
    lightbulb Created with Sketch. 820
    I know that!
    But the slide indicates that 2591 is currently in at least one Phase One trial for Retts or Fragile X.
    I don’t recall this being communicated to the market previously by Acadia.
    Anyone…?
    Last edited by sarge17: 10/01/24
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.